Aciclovir Oral: Indications, Dosing, and Precautions
Oral aciclovir guidance for herpes and zoster, including treatment, prophylaxis, and route-specific dosing.
Also searched as
Source reviewed
source date listed on the source page
Guide category
Oral drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Antiviral active against herpes simplex virus and varicella zoster virus.
Indications
- Treatment of recurrent or extensive oral and oesophageal herpes in immunocompromised patients.
- Treatment of herpetic kerato-uveitis.
- Treatment of genital herpes.
- Secondary prophylaxis of herpes in patients with frequent and/or severe recurrences.
- Treatment of severe forms of zoster: necrotic or extensive forms, facial or ophthalmic zoster.
Forms and strengths
- 200 mg and 800 mg tablets.
- Also comes in 40 mg/ml oral suspension.
Dose and duration
Treatment of recurrent or extensive oral and oesophageal herpes in immunocompromised patients; treatment of herpetic kerato-uveitis
- Child under 2 years: 200 mg 5 times daily for 7 days.
- Child 2 years and over and adult: 400 mg 5 times daily for 7 days.
Treatment of genital herpes
- Child 2 years and over and adult: 400 mg 3 times daily for 7 days.
- In immunocompromised patients, continue treatment until clinical resolution.
Secondary prophylaxis of herpes in patients with frequent and/or severe recurrences
- Child under 2 years: 200 mg 2 times daily.
- Child 2 years and over and adult: 400 mg 2 times daily.
Treatment of severe forms of zoster
- Adult: 800 mg 5 times daily for 7 days.
Contra-indications, adverse effects, precautions
- Do not administer to patients with hypersensitivity to aciclovir.
- May cause headache, skin rash, allergic reactions, gastrointestinal disturbances, and raised transaminases.
- May cause neurologic disorders in patients with renal impairment and elderly patients; rarely, haematological disorders.
- Reduce dosage in patients with renal impairment.
- Drink a lot of liquid during treatment.
- Pregnancy: no contra-indication.
- Breast-feeding: no contra-indication.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.